Philip Goelet is a scientist, entrepreneur and investor. After completing his PhD in 1982 on Tobacco Mosaic Virus at the Laboratory of Molecular Biology in Cambridge UK he worked as a post-doctoral student on learning and memory at Columbia University, NY. Over the years Philip has co-authored more than 40 publications in the fields of molecular biology, neuroscience and genomics.
Since 1990, Philip has co-founded a number of biotechnology companies including Molecular Tool, Inc., RiboTargets, Plc., Dihedron, Inc., Population Genetic Technologies, Ltd., Arginetix, Inc., ZuvaChem, LLC and AgriMetis, LLC. The majority of these companies were co-founded by Acidophil, an innovation company Sydney Brenner and Philip co-founded in 2000. During these years Philip has filed more than 20 patents.
Since 1997 Philip has co-invested with his brother Christopher Goelet in a number of venture capital firms through Red Abbey, LLC. In 2003 Philip, Frank Bonsal and Matt Zuga co-founded Red Abbey Venture Partners, a life sciences private equity fund. Since 2009 Philip continues to invest primarily in the companies founded by Acidophil.